Skip to content

Evaluation of efficacy of zoledronate gel as a local drug delivery system in the treatment of chronic pyorrhoea

A RANDOMIZED CONTROLLED CLINICAL TRIAL EVALUATING EFFICACY OF ZOLEDRONATE GEL AS A LOCAL DRUG DELIVERY SYSTEM IN THE TREATMENT OF CHRONIC PERIODONTITIS â?? A CLINICAL AND RADIOLOGICAL CORRELATION

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/05/006960
Enrollment
40
Registered
2016-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Periodontitis

Interventions

Intervention1: Bishosphonate gel: 20 µl of ZLN gel (0.005%) or the placebo gel as measured by micropipette was delivered in the already chosen sites which were the intrabony defects in the experiment

Sponsors

Abhaya Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Systemically healthy chronic periodontitis subjects (30-50 years) having pocket probing depths (PDs) more than or equal to 5mm or clinical attachment levels (CALs) more than or equal to 4mm and vertical bone loss more than or equal to 3 mm on intraoral periapical radiographs or Orthopentomograph were initially included. Only those subjects which on screening by the dentascan showed two walled or combined defects without involving the furcation with radiographic defect angle less than or equal to 45 degrees were selected for the study by an independent blinded investigator.

Exclusion criteria

Exclusion criteria: Individuals allergic to bisphosphonates or on systemic bisphosphonate therapy, tobacco & alcohol users, immunocompromised patients or having taken antibiotics within preceding 3 months, undergone periodontal surgical treatment within last 6 months, pregnant or lactating females were excluded.

Design outcomes

Primary

MeasureTime frame
full mouth plaque index , gingival index, tooth specific probing depth & clinical attachment levelTimepoint: baseline 3 months 6 months

Secondary

MeasureTime frame
defect depth, bucco-lingual width of defect, mesio-distal defect width, radiographic angle fill & volumetric bone gain percentageTimepoint: baseline 6 months

Countries

India

Contacts

Public ContactAbhaya Gupta

Babu Banarasi Das University, lucknow

govilavivek@gmail.com9415012444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026